At a Glance
Hypertriglyceridemia is a condition in which blood triglyceride levels are higher than the normal range.
Most cases are asymptomatic, but elevated blood triglycerides are associated with an increased risk of cardiovascular disease.
Disease Atlas / Disease detail
Educational summary on the definition, related factors, assessment, and management of hypertriglyceridemia
hypertriglyceridemia · hypertriglyceridemia · hypertriglyceridemia (disease)
Start with the essentials, then explore the patient and research views.
Public revision · f20a0b4269d9
A structured guide for understanding the disease and preparing for clinical conversations.
Hypertriglyceridemia is a condition in which blood triglyceride levels are higher than the normal range.
Most cases are asymptomatic, but elevated blood triglycerides are associated with an increased risk of cardiovascular disease.
Excessive caloric and sugar intake, overweight/obesity, alcohol consumption, smoking, certain medications, genetic disorders, thyroid, liver, or kidney diseases, and uncontrolled type 2 diabetes may be associated.
Metabolic abnormalities occur as excess calories consumed are converted into triglycerides and stored, and lipoproteins carrying high blood triglyceride levels transport them to tissues.
Risk and triglyceride levels vary by individual depending on dietary habits, weight, alcohol/smoking, comorbidities, medications, and genetic background.
If levels are very high, the risk of acute pancreatitis may increase, and the clinical course varies depending on the cause and duration.
Diagnosis begins with evaluating triglycerides and cholesterol through blood tests, taking into account both fasting status and clinical context.
Do not determine causes or long-term risks based on a single measurement alone; results should be interpreted in conjunction with testing conditions, repeated measurements, comorbidities, and medications taken.
Management is directed toward adjusting weight, physical activity, intake of sugars/refined foods, alcohol, smoking, and saturated fats, as well as evaluating and managing related diseases.
Lifestyle modification is fundamental, and for some individuals, pharmacotherapy may be necessary to lower triglycerides and overall cardiovascular risk.
Follow-up involves monitoring triglyceride trends alongside changes in lifestyle, comorbidities, and treatment; while NCT03911427 on ClinicalTrials.gov is registered as completed, this does not mean that results have been reported.
In clinical practice, it is possible to verify the timing of testing and fasting status, the need for repeated measurements, dietary habits, alcohol consumption, smoking, weight, diabetes, thyroid, liver, and kidney diseases, current medications, and family history.
This material is for educational purposes only and is not intended as guidance for individual diagnosis or treatment. Individual conditions and treatment decisions should be made in consultation with medical professionals.
A trial registry status does not establish efficacy or regulatory approval.
ClinicalTrials.gov · TRIAL REGISTRY
Europe PMC · BIBLIOGRAPHIC RECORD
MedlinePlus · GOVERNMENT SUMMARY
MONDO · ONTOLOGY